期刊文献+

我院2000~2006年碳青霉烯类抗生素利用分析 被引量:6

Use of Carbopenem Antibacterials in Our Hospital During 2000~2006
原文传递
导出
摘要 目的:了解我院碳青霉烯类抗生素的应用情况。方法:采用用药频度(DDDs)分析法,对我院2000~2006年碳青霉烯类抗生素的应用密度(AUD)、平均日用金额(AADC)、费用密度(ACD)进行统计、分析。结果:我院碳青霉烯类抗生素的DDDs、AUD呈逐年上升趋势;各种药品的AADC呈逐年下降趋势,但ACD有升高趋势。结论:临床应安全、有效、经济、合理地应用碳青霉烯类抗生素,以保护用于治疗细菌感染的药物资源。 OBJECTIVE:To probe into the utilization status of carbopenem antibacterials in our hospital .METHODS:The antimicrobial use density(AUD), the antimicrobial average daily cost(AADC), and the antimicrobial cost density(ACD) of carbopenem antibacterials used in our hospital during 2000~2006 were analyzed statistically using DDDs analytical method. RESULTS: DDDs and AUD of the carbopenem antibacterials used in our hospital showed an upward trend; the AADC of each kind was decreasing year by year but ACD presented an upward trend.CONCLUSION:Safe,effective,economical and rational use of carbopenem antibacterials is in the interest of protection of drug resources used for bacterial infection.
机构地区 海南省人民医院
出处 《中国药房》 CAS CSCD 北大核心 2007年第35期2744-2745,共2页 China Pharmacy
关键词 碳青霉烯类 抗菌药物 用药频度 Carbopenems Antibacterials DDDs
  • 相关文献

参考文献4

二级参考文献30

  • 1刘萍,边强.碳青霉烯类抗生素ertapenem[J].世界临床药物,2004,25(7):441-441. 被引量:3
  • 2范亚平.细菌对碳青霉烯类抗生素耐药的机制及对策[J].中国医学文摘(内科学),2005,26(1):123-125. 被引量:3
  • 3Bowker K E,:Hols H A,Rccves D S.Bactericidal activity postantibiotic effect and modified controlled effective regowth time of meropenem at high concentrations[J].J Antimicrob Chemother,1996,38(6):1055 被引量:1
  • 4Ronald N J,Holly K H,Biedenbach D J,et al.Doripenem (S-4661),a novel carbapenem:comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations[J].J Antimicrob Chemother,2004,54:144 被引量:1
  • 5Yoshiaki K,Masako O,Takeshi N.Antibacterial properties of BO-2727,a new carbapenem antibiotic[J].J Antimicrob Chenmother,1997,40:195 被引量:1
  • 6Thomson K S,Moland S.CS-023(R-115685),a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa[J].J Antimicrob Chemothcr,2004,54(2):557 被引量:1
  • 7Shuichi M,Takayuki H,Nobuhiko F.In vitro andin vivo antibacterial activities of 1-084,a novel oral carbapenem,against causative organisms of respiratory tract infections[J].Antimicrob Agents Chemother,2001,45(1):203 被引量:1
  • 8Kato Y,Otsuki M,Nishino T.Antibacterial properties of BO-2727,a new carbapenem antibiotic[J].J Antimicrob Chemother,1997,40:195 被引量:1
  • 9Fuminori O,Mayumi N,Nao-aki Watanabe,et al.In vitro and in vivo antibacterial activities of er-35786,new antipseudomonal carbapenem[J].Antimicrob Aggnts ChemotheL 1997,41(2):298 被引量:1
  • 10Umenura K,Ikeda Y,Kondo K,et al.Safety and pharmacokinetics of CS-834,a new oral carbapenem antibiotic,in healthy volunteers[J].Antimicrob Agent Chemother,1997,41(12):2664 被引量:1

共引文献73

同被引文献34

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部